WebDec 1, 2024 · Bydureon is an injectable prescription medicine that may improve blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 … WebBYDUREON (exenatide) for extended-release injectable suspension is a GLP-1 receptor agonist supplied as a sterile powder to be suspended in diluent and administered by subcutaneous injection. Exenatide is a 39-amino acid synthetic peptide amide with an empirical formula of C184H282N50O60S and a molecular weight of 4186.6 Daltons.

Bydureon Subcutaneous: Uses, Side Effects, Interactions

WebThe diluent for the BYDUREON Pen is contained within each single -dose pen. Each configuration contains sufficient diluent to deliver 0.65 mL. The diluent is a clear, colorless to pale-yellow solution composed of carboxymethylcellulose sodium (19 mg), polysorbate 20 (0.63 mg), sodium phosphate monobasic monohydrate (0.61 mg), sodium phosphate ... WebBydureon comes with an extra patient information sheet called a Medication Guide and Instructions for Use. Read them carefully. Read them again each time you get Bydureon refilled. Use Bydureon with or without food once every 7 days (weekly). A health care provider will teach you how to use Bydureon. Be sure you understand how to use … lithium in chemistry

Bydureon Pen Uses, Side Effects & Warnings - Drugs.com

WebSep 17, 2024 · Bydureon Pen subcutaneous suspension for injection, AstraZeneca, 2 mg, 0.65 mL pen injector, 4 count, NDC 00310-6530-04 Updated Created March 20, 2024 by … WebSep 11, 2024 · WARNING: RISK OF THYROID C-CELL TUMORS See full prescribing information for complete boxed warning. • Exenatide extended-release causes thyroid C-cell tumors at clinically relev WebBydureon Pen Injector 2 mg/0.65 mL September 24, 2024 . SHARE THIS. Bydureon Pen Injector 2 mg/0.65 mL. Uses. For diabetes. Instructions. This medicine is used by … impure thesaurus